Study identifier:NIS-OES-XXX-2012/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Observational retrospective study to describe the management of advanced or metastatic EGFR (Epidermal Growth Factor Receptor) mutated non-small cell lung cancer patients in Spain
EGFR mutated non-small cell lung cancer patients
N/A
No
-
All
187
Observational
18 Years - 99 Years
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Sept 2014 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|